HomeNewsUs deal

Us Deal

Jump to

Capacity debottlenecking led to growth: Shasun Pharma

Abhaya Kumar, managing director, Shasun Pharmaceuticals Ltd says that capacity debottlenecking and higher customer demand contributed to 40% y-o-y growth. He also says that the company expects 25% growth in EPS of the company in FY13.
Expect US deal to boost 2012 revenues: Hexaware Tech

"The deal has been signed with an existing client in North America for infra management and business process outsourcing services," said Atul Nishar, its chairman in an exclusive interview with CNBC-TV18.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Us Deal

Capacity debottlenecking led to growth: Shasun Pharma

Expect US deal to boost 2012 revenues: Hexaware Tech